ELCC 2017

1:33
Exciting current topics in lung cancer
Solange Peters
1:13
Phase II study of Durvalumab for patients with NSCLC
David Gandara
1:48
Evolving guidelines for molecular testing in lung cancer
Fred Hirsch
0:51
Current treatment landscape for neuroendocrine tumors
Keith Kerr
2:04
Biomarker testing in NSCLC
Keith Kerr
1:29
The LUME-BioNIS study and its aims
Keith Kerr
1:10
The BIRCH trial data discussed by Dr Peters
Solange Peters
2:29
The open questions surrounding immunotherapy and targeted therapy in lung cancer
Solange Peters
1:46
Challenges and opportunities for patients with advanced NSCLC
Solange Peters
2:43
Increasing patient access to the latest treatments
Solange Peters
0:47
Why is European Lung Cancer Conference so important?
Solange Peters
1:15
Molecular tools for lung cancer therapies
Charles Swanton
2:09
Benefits of targeted therapeutics in Lung Cancer
David Carbone
2:07
Increasing treatment options for NSCLC
David Gandara
2:09
Genetic evolution of NSCLC
Charles Swanton
1:35
NSCLC: identifying patients most likely to relapse
Charles Swanton
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals